Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-05
2011-07-05
Fetterolf, Brandon (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07973046
ABSTRACT:
Allopurinol or a pharmaceutically acceptable salt thereof can be used for the treatment or prevention of palmar plantar erythrodysesthesia induced by chemotherapy. The allopurinol or its salt may be administered topically to the affected areas, palms and soles, preferably in the form of a cream.
REFERENCES:
patent: 4943575 (1990-07-01), Cremer
patent: 6060083 (2000-05-01), Dorr et al.
patent: 6685917 (2004-02-01), Rosenthal et al.
patent: 6979688 (2005-12-01), Ford
patent: 2002/0119104 (2002-08-01), Rosenthal et al.
patent: 2003/0060486 (2003-03-01), Jacob et al.
patent: 2003/0157191 (2003-08-01), Kil et al.
patent: 2004/0214215 (2004-10-01), Yu et al.
patent: 2005/0142093 (2005-06-01), Skover et al.
patent: 2006/0177374 (2006-08-01), Curd et al.
patent: 2006/0178351 (2006-08-01), Curd et al.
patent: 3106817 (1991-05-01), None
patent: 0606700 (2006-02-01), None
patent: 9405291 (1994-03-01), None
patent: 9405293 (1994-03-01), None
patent: 2004110380 (2004-12-01), None
International Search Report issued by the International Searching Authority (ISA/O.E.P.M.) on Aug. 10, 2007, in connection with International Application No. PCT/ES2007/070097.
DE 102 00 578 A1 (Roehm GMBH [DE]) Jul. 10, 2003.
WO 03/018102 A2 (Vectura Ltd [GB]; Tobyn Michael John [GB]; Staniforth John Nicolas [GB]) Mar. 6, 2003.
WO 2006/030439 A (Biomas Ltd [IL]; Albeck Michael [IL]; Sredni Benjamin [IL]) Mar. 23, 2006.
El-on J. et al., “Development of Topical Treatment For Cutaneous Leishmaniasis Caused By Leishmania-Major In Experimental Animals” Antimicrobial Agents And Chemotherapy, vol. 26, No. 5, 1984, pp. 745-751, XP009075856 ISSN:0066-4804.
Dagher G. et al., “Allopurinol Mouthwash And Vaginal Cream For 5-Fu-Induced Mucositis” Canadian Journal of Hospital Pharmacy, vol. 40, No. 5, 1987, p. 189, XP009075859 ISSN:0008-4123.
Gilbar P., “Palmar-plantar erythrodysesthesia” Journal of Oncology Pharmacy Practice 2003 United States, vol. 9, No. 4, 2003, pp. 137-150, XP002410373 ISSN:1078-1552.
Tsavaris N. et al., “Concomitant Administration of 4 Hydroxypyrazolopyrimidine Allopurinol and High-Dose Continuous Infusion 5 Flurouracil” Oncology (Basel), vol. 47, No. 1, 1990, pp. 70-74, XP009075852 ISSN:0030-2414.
Chin, S.F., “Use of “Bag Balm” as Topical Treatment of Palmar-Planrtar Erythrodysesthesia Syndrome (PPES) in Patients Receiving Selected Chemotherapeeutic Agents”, Proc Am Soc Clin Oncol., (2001); 20: Abstract 1623.
Hanawa, T., “Development of patient-friendly preparations: preparation of a new allopurinol mouthwash containing polyethylene(oxide) and carrageenan”, Drug Dev Ind Pharm., (2004); 30(2):151-61, Abstract.
Lauman MK et al., “Effect of Pyridoxine on the Incidence of Palmar Plantar Erythroderma (PPE) in Patients Receiving Capecitabine”, Proc Am Soc Clin Oncol. (2001); 20: Abstract 1565.
Nagore, E. et al., “Antineoplastic Therapy-Induced Palmar Plantar Erythrodysesthesia (‘Hand-Foot’) Syndrome”, Am J. Clin Dermatol. (2000);1(4):225-34.
Porta, C., M.D., “Allopurinol Mouthwashes in the Treatment of 5-Fluorouracil-Induced Stomatitis”, Am J. Clin Oncol. (1994) 17(3):246-7.
Webster-Gandy, J.D., “Palmar-plantar erythrodysesthesia (PPE): A literature review with commentary on experience in a cancer centre”, European Journal of Oncology Nursing (2007); 11(3); 238-46.
Wilkes, G.M., “Palmar-Plantar Erythrodysesthesia”, Clinical J. Oncol. Nursing (2005); 9(1):103-106.
Woolley, PV., “A controlled trial of the effect of 4-hydroxypyrazolopyrimidine (allopurinol) on the toxicity of a single bolus dose of 5-fluorouracil”, J. Clin Oncol. (1985) 3(1):103-9.
European Search Report issued by the International Searching Authority (ISA/O.E.P.M.) on Dec. 18, 2006 in connection with International Application No. PCT/EP2006/011432.
Cooper & Dunham LLP
Fetterolf Brandon
Gembeh Shirley V
Gershik Gary J.
Nobera Pharma, S.L.
LandOfFree
Use of allopurinol for the treatment of palmar plantar... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of allopurinol for the treatment of palmar plantar..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of allopurinol for the treatment of palmar plantar... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2639140